These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 30040140)

  • 41. Fracture liaison service in a non-regional orthopaedic clinic--a cost-effective service.
    Ahmed M; Durcan L; O'Beirne J; Quinlan J; Pillay I
    Ir Med J; 2012 Jan; 105(1):24, 26-7. PubMed ID: 22397210
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fracture liaison service model: treatment persistence 5 years later.
    Naranjo A; Molina A; Quevedo A; Rubiño FJ; Sánchez-Alonso F; Rodríguez-Lozano C; Ojeda S
    Arch Osteoporos; 2021 Apr; 16(1):60. PubMed ID: 33813663
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Critical impact of patient knowledge and bone density testing on starting osteoporosis treatment after fragility fracture: secondary analyses from two controlled trials.
    Majumdar SR; McAlister FA; Johnson JA; Weir DL; Bellerose D; Hanley DA; Russell AS; Rowe BH
    Osteoporos Int; 2014 Sep; 25(9):2173-9. PubMed ID: 24803330
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Does bisphosphonate-based anti-osteoporosis medication affect osteoporotic spinal fracture healing?
    Ha KY; Park KS; Kim SI; Kim YH
    Osteoporos Int; 2016 Feb; 27(2):483-8. PubMed ID: 26202489
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy and safety of teriparatide in bisphosphonate-pretreated and treatment-naive patients with osteoporosis at high risk of fracture: Post hoc analysis of a prospective observational study.
    Yoshiki F; Nishikawa A; Taketsuna M; Kajimoto K; Enomoto H
    J Orthop Sci; 2017 Mar; 22(2):330-338. PubMed ID: 28038880
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Understanding fragility fracture patients' decision-making process regarding bisphosphonate treatment.
    Wozniak LA; Johnson JA; McAlister FA; Beaupre LA; Bellerose D; Rowe BH; Majumdar SR
    Osteoporos Int; 2017 Jan; 28(1):219-229. PubMed ID: 27423660
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of interactive voice response technology on primary adherence to bisphosphonate therapy: a randomized controlled trial.
    Cizmic AD; Heilmann RM; Milchak JL; Riggs CS; Billups SJ
    Osteoporos Int; 2015 Aug; 26(8):2131-6. PubMed ID: 25956282
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cost Analysis of a Fracture Liaison Service: A Randomized Controlled Trial for the Secondary Prevention After Fragility Fractures of the Hip.
    Zinger G; Davidson A; Sylvetsky N; Levy Y; Peyser A
    Endocr Pract; 2023 Oct; 29(10):794-802. PubMed ID: 37541586
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Preventing future fractures: effectiveness of an orthogeriatric fracture liaison service compared to an outpatient fracture liaison service and the standard management in patients with hip fracture.
    Naranjo A; Fernández-Conde S; Ojeda S; Torres-Hernández L; Hernández-Carballo C; Bernardos I; Rodríguez S; Laynez P
    Arch Osteoporos; 2017 Dec; 12(1):112. PubMed ID: 29230540
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lessons Learned: Evaluation of Fracture Liaison Service Quality Improvement Efforts in a Large Academic Healthcare System.
    Billups SJ; Fixen DR; Schilling LM; El-Sheikh A; Marcus AM; Rothman MS
    J Gen Intern Med; 2024 Jun; 39(8):1407-1413. PubMed ID: 38100010
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A randomized study of two different information-based interventions on the management of osteoporosis in minimal and moderate trauma fractures.
    Bliuc D; Eisman JA; Center JR
    Osteoporos Int; 2006; 17(9):1309-17. PubMed ID: 16804739
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Total Hip Bone Mineral Density as an Indicator of Fracture Risk in Bisphosphonate-Treated Patients in a Real-World Setting.
    Banefelt J; Timoshanko J; Söreskog E; Ortsäter G; Moayyeri A; Åkesson KE; Spångéus A; Libanati C
    J Bone Miner Res; 2022 Jan; 37(1):52-58. PubMed ID: 34585781
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cost-effectiveness of bisphosphonate therapies for women with postmenopausal osteoporosis: implications of improved persistence with less frequently administered oral bisphosphonates.
    Earnshaw SR; Graham CN; Ettinger B; Amonkar MM; Lynch NO; Middelhoven H
    Curr Med Res Opin; 2007 Oct; 23(10):2517-29. PubMed ID: 17825128
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Fracture Liaison Service and Osteoporosis Liaison Service.].
    Hagino H
    Clin Calcium; 2017; 27(9):1225-1231. PubMed ID: 28912384
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Percutaneous vertebroplasty for osteoporotic vertebral compression fracture.
    Buchbinder R; Golmohammadi K; Johnston RV; Owen RJ; Homik J; Jones A; Dhillon SS; Kallmes DF; Lambert RG
    Cochrane Database Syst Rev; 2015 Apr; (4):CD006349. PubMed ID: 25923524
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of a Multimodal, Direct-to-Patient Educational Intervention Targeting Barriers to Osteoporosis Care: A Randomized Clinical Trial.
    Danila MI; Outman RC; Rahn EJ; Mudano AS; Redden DT; Li P; Allison JJ; Anderson FA; Wyman A; Greenspan SL; LaCroix AZ; Nieves JW; Silverman SL; Siris ES; Watts NB; Miller MJ; Curtis JR; Warriner AH; Wright NC; Saag KG
    J Bone Miner Res; 2018 May; 33(5):763-772. PubMed ID: 29377378
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Osteoporotic fracture rate among women with at least 1 year of adherence to osteoporosis treatment.
    Modi A; Tang J; Sen S; Díez-Pérez A
    Curr Med Res Opin; 2015 Apr; 31(4):767-77. PubMed ID: 25708648
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bisphosphonate use after clinical fracture and risk of new fracture.
    Bergman J; Nordström A; Nordström P
    Osteoporos Int; 2018 Apr; 29(4):937-945. PubMed ID: 29397408
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Vitamin D analogs versus native vitamin D in preventing bone loss and osteoporosis-related fractures: a comparative meta-analysis.
    Richy F; Schacht E; Bruyere O; Ethgen O; Gourlay M; Reginster JY
    Calcif Tissue Int; 2005 Mar; 76(3):176-86. PubMed ID: 15692726
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.